Printer Friendly

DIAGNOSTEK RESPONDS TO TRADING ACTIVITY

 DIAGNOSTEK RESPONDS TO TRADING ACTIVITY
 ALBUQUERQUE, N.M., June 3 /PRNewswire/ -- Diagnostek, Inc.


(NYSE: DXK) said that in view of the unusual market activity in the company's stock, the New York Stock Exchange has contacted the company and requested that a public statement be issued indicating whether there are any corporate developments which may explain the unusual market activity. The company said that it was unaware of any corporate development that would explain such activity.
 -0- 6/3/92
 /CONTACT: Vincent Villanueva or Dennis E. Evans both of Diognostek, 505-345-8080/
 (DXK) CO: Diagnostek, Inc. ST: New Mexico IN: SU:


LR -- NY071 -- 6726 06/03/92 16:29 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 3, 1992
Words:108
Previous Article:SHARES OF THE PHOENIX RESOURCE COMPANIES, INC. TO TRADE IN NASDAQ NATIONAL MARKET
Next Article:BOEING/TEAGUE TEAM WINS DESIGN AWARD FOR 777 INTERIOR
Topics:


Related Articles
DIAGNOSTEK APPOINTS DUKE RODRIGUEZ COO
DIAGNOSTEK NAMES WILLIAM A. BARRON CHIEF FINANCIAL OFFICER
DIAGNOSTEK CONFIRMS CONTINUATION OF FORD RELATIONSHIP
DIAGNOSTEK ANNOUNCES NEW PRESCRIPTION CREDIT CARD PRODUCT SPONSORED WITH THE NATIONAL RURAL ELECTRIC COOPERATIVE ASSOCIATION
DIAGNOSTEK REPORTS $0.15 PER SHARE FOURTH QUARTER NET EARNINGS BEFORE SETTLEMENT CHARGES; TOTAL YEAR REVENUES UP 27% FROM PRIOR YEAR
DIAGNOSTEK'S WILLIAM BARRON ADDS COO TITLE FOLLOWING RESIGNATION OF DUKE RODRIGUEZ
DIAGNOSTEK CONFIRMS CHRYSLER PRESCRIPTION DRUG CONTRACT
DIAGNOSTEK AUTHORIZED TO PROCEED WITH NEW JERSEY CONTRACT
VALUE HEALTH, INC. & DIAGNOSTEK RENEGOTIATE MERGER AGREEMENT
DIAGNOSTEK REPORTS FISCAL YEAR 1995 RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters